Exhibit 10.1


 


 


ASCENT SOLAR TECHNOLOGIES,
INC.


 


COMMON STOCK PURCHASE
AGREEMENT


 


THIS COMMON
STOCK PURCHASE AGREEMENT (the “Agreement”) is entered into as of the 4th day of March, 2021 (the “Effective
Date”) by and among ASCENT SOLAR TECHNOLOGIES, INC., a Delaware corporation (the “Company”), and the persons
or entities named on the executed counterpart signature pages attached hereto (the “Purchaser”).


 


RECITALS


 


WHEREAS,
the Company has authorized the sale and issuance of up to an aggregate of 75,000,000 shares of its Common Stock (the “Shares”);
and


 


WHEREAS, the
Company desires to issue and sell the Shares to Purchaser on the terms and conditions set forth herein.


 


NOW, THEREFORE,
in consideration of the foregoing, and the representations, warranties, covenants and conditions set forth below, the Company and
each Purchaser, intending to be legally bound, hereby agree as follows:


 


		1.	AGREEMENT TO SELL AND PURCHASE.



 


1.1              
Authorization of Shares. The Company has authorized the sale and issuance to the Purchaser of the Shares. The Shares
have the rights, preferences, privileges and restrictions set forth in the Company’s Certificate of Incorporation, as amended
to date (the “Charter”).


 


1.2              
Sale and Purchase. Subject to the terms and conditions hereof, at the Closing (as defined below), the Company hereby
agrees to issue and sell to Purchaser, and Purchaser agrees to purchase from the Company, 75,000,000 Shares, at a purchase price
of $0.04 per share (the “Purchase Price”).


 


		2.	THE CLOSING.



 


2.1              
Closing Date. The closing of the sale and purchase of the Shares (the “Closing”) shall be held on or
before March 10, 2021 (the “Closing Date”).


 


2.2              
Delivery. At the Closing, subject to the terms and conditions hereof, the Company will deliver to the Purchaser a
Book Entry statement representing the number of Shares to be purchased at such Closing by the Purchaser, against payment of the
Purchase Price therefor by check or wire transfer made in accordance with the Company’s instructions.


 


2.3              
Registration Rights. The Company hereby agrees to make commercially reasonable best efforts to (i) prepare and file
one or more a resale registration statements (the “Resale Registration”) with the Securities Exchange Commission (“SEC”)
promptly following the Company’s filing with the SEC of its Forms 10-Q for the quarters ended March 31, 2020, June 30, 2020
and September 30, 2020, and its Form 10-K for the year ended December 31, 2020, (ii) cause such Resale Registration to be declared
effective by the SEC as soon as reasonably practicably after the filing thereof, and (iii) cause such Resale Registration to remain
effective until such time as all of the registered shares (x) have been sold pursuant to the Resale Registration or (y) may be
sold without volume or manner-of-sale securities law restrictions and without the requirement for the Company to be in compliance
with the current public information requirements under applicable securities laws. The Resale Registration shall register all of
the Shares.


 


 




    	1  





    	 



    


		3.	REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY.



 


Except as
set forth in the SEC Reports or the Disclosure Schedules, which SEC Reports and Disclosure Schedules shall be deemed a part hereof
and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the SEC Reports and Disclosure Schedules, the Company hereby makes the following representations and warranties to the Purchaser
as follows:


 


3.1              
Organization, Good Standing and Qualification. The Company is a corporation duly organized, validly existing and
in good standing under the laws of the State of Delaware. The Company has all requisite corporate power and authority to own and
operate its properties and assets, to execute and deliver this Agreement, to issue and sell the Shares, to carry out the provisions
of this Agreement, and to carry on its business as presently conducted and as presently proposed to be conducted.


 


3.2              
Authorization. All corporate action on the part of the Company, its directors and its stockholders necessary for
the authorization, execution, delivery and performance of this Agreement by the Company and
the performance of the Company’s obligations hereunder, including the issuance and delivery of the Shares, has been
taken or will be taken prior to the issuance of the Shares. This Agreement, when executed and delivered by the Company, shall constitute
valid and binding obligations of the Company enforceable in accordance with its terms, subject to laws of general application relating
to bankruptcy, insolvency, the relief of debtors and, with respect to rights to indemnity, subject to federal and state securities
laws.


 


3.3            
Capitalization. The capitalization of the Company is as set forth on
the Disclosure Schedule. Except as set forth on the Disclosure Schedule, the Company has not issued any capital stock since its
most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under
the Company’s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company’s employee
stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the
most recently filed periodic report under the Exchange Act. All of the outstanding shares of capital stock of the Company are duly
authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities
laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or
purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for
the issuance and sale of the Shares. The Shares, when issued, paid for and delivered in accordance with the terms of this Agreement,
will be duly authorized, validly issued, fully paid and nonassessable and not subject to preemptive rights.


 


3.4              
Governmental Consents. All consents, approvals, orders, or authorizations of, or registrations, qualifications, designations,
declarations, or filings with, any governmental authority, required on the part of the Company in connection with the valid execution
and delivery of this Agreement, the offer, sale or issuance of the Shares or the consummation of any other transaction contemplated
hereby shall have been obtained and will be effective at the Closing.


 


3.5              
Compliance with Laws. To its knowledge, the Company is not in violation of any applicable statute, rule, regulation,
order or restriction of any domestic or foreign government or any instrumentality or agency thereof in respect of the conduct of
its business or the ownership of its properties, which violation of which would materially and adversely affect the business, assets,
liabilities, financial condition, operations or prospects of the Company.


 


 




    	2  





    	 



    


3.6              
Compliance with Other Instruments. The Company is not in violation or default of any term of the Charter or its bylaws,
or of any provision of any mortgage, indenture or contract to which it is a party and by which it is bound or of any judgment,
decree, order or writ, other than such violation(s) that would not have a material adverse effect on the Company. The execution,
delivery and performance of this Agreement, and the consummation of the transactions contemplated hereby or thereby will not result
in any such violation or be in conflict with, or constitute, with or without the passage of time and giving of notice, either a
default under any such provision, instrument, judgment, decree, order or writ or an event that results in the creation of any lien,
charge or encumbrance upon any assets of the Company or the suspension, revocation, impairment, forfeiture, or nonrenewal of any
material permit, license, authorization or approval applicable to the Company, its business or operations or any of its assets
or properties.


 


		3.7	Offering



 (a)               
Assuming the accuracy of the representations and warranties of the Purchasers contained in Section 4 hereof, the offer,
issue, and sale of the Shares are and will be exempt from the registration and prospectus delivery requirements of the Securities
Act of 1933, as amended (the “Act”), and have been registered or qualified (or are exempt from registration and qualification)
under the registration, permit, or qualification requirements of all applicable state securities laws.


 


(b)               
No “Bad Actor”
Disqualification. The Company has exercised reasonable care to determine whether any Company Covered Person (as defined below)
is subject to any of the “bad actor” disqualifications described in Rule 506(d)(1)(i) through (viii), as modified by
Rules 506(d)(2) and (d)(3), under the Securities Act (“Disqualification Events”). To the Company’s knowledge,
no Company Covered Person is subject to a Disqualification Event. The Company has complied, to the extent required, with any disclosure
obligations under Rule 506(e) under the Securities Act. For purposes of this Agreement, “Company Covered Persons”
are those persons specified in Rule 506(d)(1) under the Securities Act; provided, however, that Company Covered Persons do not
include (a) any Purchaser, or (b) any person or entity that is deemed to be an affiliated issuer of the Company solely as a result
of the relationship between the Company and any Purchaser.


 


		3.8	SEC Filings; Financial Statements.



 


(a)               
Except as set forth on the Disclosure Schedule, the Company has timely filed all forms, reports and documents (including
all exhibits) required to be filed by it with the SEC since January 1, 2019 (the “SEC Reports”). The SEC Reports (i)
were prepared in accordance with the requirements of the Act and the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and the rules and regulations promulgated thereunder and (ii) did not at the time they were filed contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements
made therein, in the light of the circumstances under which they were made, not misleading.


 


(b)               
Each of the financial statements (including, in each case, any notes thereto) contained in the SEC Reports was prepared
in accordance with United States generally accepted accounting principles (“GAAP”) applied on a consistent basis throughout
the periods indicated (except as may be indicated in the notes thereto) and the Company’s books and records, and each fairly
presented the financial position, results of operations and cash flows of the Company as at the respective dates thereof and for
the respective periods indicated therein except as otherwise noted therein (subject, in the case of unaudited statements, to normal
year-end adjustments which individually or in the aggregate did not have, and would not reasonably be expected to have, a material
adverse effect on the business, operations, assets, liabilities, financial condition or results of operations of the Company).
The books and records of the Company have been, and are being, maintained in accordance with applicable legal and accounting requirements
in all material respects.


 


 




    	3  





    	 



    


3.9              
Further Assurances. The Company agrees and covenants that at any time and from time to time it will promptly execute
and deliver to the Purchaser such further instruments and documents and take such further action as the Purchaser may reasonably
require in order to carry out the full intent and purpose of this Agreement and to comply with state or federal securities laws
or other reasonable requests that the Purchaser may require.





 


		4.	REPRESENTATIONS AND WARRANTIES OF THE PURCHASER.



 


Purchaser
hereby represents and warrants to the Company as follows (provided that such representations and warranties do not lessen or obviate
the representations and warranties of the Company set forth in this Agreement):


 


4.1              
Purchase for Own Account. Purchaser represents that it is acquiring the Shares for its own account and not with a
view towards, or for resale in connection with, a public sale or distribution thereof in violation of applicable securities laws,
except pursuant to sales registered or exempted under the Act; notwithstanding the forgoing, by making the representations
herein, Purchaser does not agree, or make any representation or warranty, to hold any of the Shares for any minimum or other specific
term and reserves the right to dispose of the Shares at any time in accordance with or pursuant to a registration statement or
an applicable exemption under the Act. Purchaser does not presently have any agreement or understanding, directly or indirectly,
with any Person to distribute any of the Shares in violation of applicable securities laws.


 


4.2              
Information and Sophistication. Purchaser hereby: (i) acknowledges that it has received all the information it has
requested from the Company and it considers necessary or appropriate for deciding whether to acquire the Shares, (ii) represents
that it has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the
offering of the Shares and to obtain any additional information necessary to verify the accuracy of the information given the Purchaser
and (iii) further represents that it has such knowledge and experience in financial and business matters that it is capable of
evaluating the merits and risks of this investment.


 


4.3              
Ability to Bear Economic Risk. Purchaser acknowledges that investment in the Shares involves a high degree of risk,
and represents that it is able, without materially impairing its financial condition, to hold the Shares for an indefinite period
of time and to suffer a complete loss of its investment.


 


4.4              
Rule 144. Purchaser acknowledges and agrees that the Shares are “restricted securities” as defined in
Rule 144 promulgated under the Act as in effect from time to time and must be held indefinitely unless they are subsequently registered
under the Act or an exemption from such registration is available. Purchaser has been advised or is aware of the provisions of
Rule 144, which permits limited resale of shares purchased in a private placement subject to the satisfaction of certain conditions.
Purchaser acknowledges that the Company has no obligation to register the Shares for resale.


 


4.5              
Legends. Purchaser acknowledges and agrees that the Shares may bear one or all of the following legends:


 


(a)               
“THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH
SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION


 


 




    	4  





    	 



    


OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY
THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933 AS AMENDED.”


 


(b)               
Any legend required by the state securities laws of any U.S. state to the extent such laws are applicable to the shares
represented by the certificate so legended.


 


4.6              
Accredited Investor Status. At the time Purchaser was offered the Shares, it was, and as of the date hereof it is,
either (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities
Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act.


 


4.7              
No “Bad Actor” Disqualification. Purchaser represents and warrants that neither (A) the Purchaser nor
(B) any entity that controls the Purchaser or is under the control of, or under common control with, the Purchaser, is subject
to any Disqualification Event, except for Disqualification Events covered by Rule 506(d)(2)(ii) or (iii) or (d)(3) under the Securities
Act and disclosed in writing in reasonable detail to the Company. The Purchaser represents that the Purchaser has exercised reasonable
care to determine the accuracy of the representation made by the Purchaser in this paragraph, and agrees to notify the Company
if the Purchaser becomes aware of any fact that makes the representation given by the Purchaser hereunder inaccurate.


 


4.8              
Residence. If Purchaser is an individual, then Purchaser resides in
the jurisdiction identified in the address of Purchaser set forth on the executed counterpart signature page attached hereto. If
Purchaser is a partnership, corporation, limited partnership, limited liability company or other entity, then the office or offices
of Purchaser in which its investment decision was made is located at the address or addresses of Purchaser set forth on the executed
counterpart signature page attached hereto.


 


4.9              
Further Assurances. Purchaser agrees and covenants that at any time and from time to time it will promptly execute
and deliver to the Company such further instruments and documents and take such further action as the Company may reasonably require
in order to carry out the full intent and purpose of this Agreement and to comply with state or federal securities laws or other
regulatory approvals.


 


		5.	CONDITIONS TO CLOSING.



 


5.1              
Conditions to Purchasers’ Obligations at the Closing. Purchaser’s obligations to purchase the Shares
at the Closing are subject to the satisfaction, at or prior to the Closing Date, of the following conditions:


 


(a)               
Representations and Warranties True; Performance of Obligations. The representations and warranties made by the Company
in Section 3 hereof shall be true and correct in all material respects as of the Closing with the same force and effect as if they
had been made as of the Closing, and the Company shall have performed all obligations and conditions herein required to be performed
or observed by it on or prior to the Closing.


 


(b)               
Consents, Permits, and Waivers. The Company shall have obtained any and all consents, permits and waivers necessary
or appropriate for consummation of the transactions contemplated by the Agreement, except for such as may be properly obtained
subsequent to the Closing.


 


(c)               
Proceedings and Documents. All corporate and other proceedings in connection with the transactions contemplated at
the Closing hereby and all documents and instruments incident to such transactions shall be reasonably satisfactory in substance
and form to Purchasers, and Purchasers shall


 


 




    	5  





    	 



    


have received all such counterpart originals or
certified or other copies of such documents as they may reasonably request.


 


5.2              
Conditions to Obligations of the Company. The Company’s obligation to issue and sell the Shares
at the Closing is subject to the satisfaction, at or prior to the Closing Date, of the following conditions:


 


(a)               
Representations and Warranties True. The representations and warranties in Section 4 made by the Purchaser acquiring
Shares hereof shall be true and correct in all material respects at the date of the Closing, with the same force and effect as
if they had been made on and as of said date.


 


(b)               
Consents, Permits, and Waivers. The Company shall have obtained any and all consents, permits and waivers necessary
or appropriate for consummation of the transactions contemplated by this Agreement, except for such as may be properly obtained
subsequent to the Closing.


 


		6.	MISCELLANEOUS.



 


6.1              
Use of Proceeds. The Company agrees that the proceeds of the sale of the Shares will be used for working capital
and general corporate purposes of the Company. The Company shall not use any such proceeds to make any distributions on, or payments
in respect of, any outstanding equity securities of the Company.


 


6.2              
Binding Agreement. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the
respective successors and assigns of the parties. Nothing in this Agreement, expressed or implied, is intended to confer upon any
third party any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided
in this Agreement.


 


6.3              
Governing Law. This Agreement shall be governed by and construed under the laws of the State of Delaware, without
giving effect to conflicts of laws principles.


 


6.4              
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument.


 


6.5              
Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to
be considered in construing or interpreting this Agreement.


 


6.6              
Notices. All notices required or permitted hereunder shall be in writing
and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed telex,
electronic mail or facsimile if sent during normal business hours of the recipient, if not, then on the next business
day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid,
or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification
of receipt. All communications shall be sent to the Company and to the Purchaser at the address set forth on the executed counterpart
signature pages attached hereto or at such other address as the Company or a Purchaser may designate by ten (10) days advance written
notice to the other parties hereto.


 


6.7              
Modification; Waiver. No modification or waiver of any provision of this Agreement or consent to departure therefrom
shall be effective unless in writing and approved by the Company and the Purchaser. Any such amendment or modification shall be
binding on all parties hereto.


 


6.8              
Expenses. The Company and the Purchaser shall each bear its respective
expenses and legal fees incurred with respect to this Agreement and the transactions contemplated herein.


 


 




    	6  





    	 



    


6.9              
Delays or Omissions. It is agreed that no delay or omission to exercise any right, power or remedy accruing to the
Purchaser, upon any breach or default of the Company under this Agreement shall impair any such right, power or remedy, nor shall
it be construed to be a waiver of any such breach or default, or any acquiescence therein, or of or in any similar breach or default
thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore
or thereafter occurring. It is further agreed that any waiver, permit, consent or
approval of any kind or character by the Purchaser of any breach or default under this Agreement, or any waiver by the Purchaser
of any provisions or conditions of this Agreement must be in writing and shall be effective only to the extent specifically set
forth in writing and that all remedies, either under this Agreement, or by law or otherwise afforded to the Purchaser, shall be
cumulative and not alternative.


 


6.10          
Entire Agreement. This Agreement constitutes the full and entire understanding and agreement between the parties
with regard to the subjects hereof and no party shall be liable or bound to any other party in any manner by any representations,
warranties, covenants and agreements except as specifically set forth herein.


 


[Remainder of page intentionally
left blank. Signature page follows.]


 


 


 




    	7  





    	 



    

IN WITNESS WHEREOF, the parties
have executed this STOCK PURCHASE AGREEMENT as of the date first written above.


 


ASCENT SOLAR TECHNOLOGIES, INC.


 


 


By: /s/ Victor Lee        


Name: Victor Lee


Title: President & CEO


 


12300 Grant Street


Thornton, CO 80241


Email: [***]


 


 


 


BAYBRIDGE CAPITAL FUND, LP


 


By:  /s/ David E. Price          


Name: David E. Price


Title: Authorized Signatory


 


Address:#3 Bethesda Metro Center Suite 700


Bethesda, Md 20814


[***]


 


 


 






    	8